Dr H H Gunson (National Blood Transfusion Service, Manchester) Some Serological Aspects
It is now well established that hemolytic disease of the newborn is caused by damage to the red cells of the feetus and newborn infant by blood group antibodies derived from the maternal circulation' Antibodies of many different specificities have been implicated in the causation of hmmolytic disease, although the two blood group systems most frequently involved are the ABO and Rh.
Apart from specificity, the globulin nature of an antibody plays an important part in the ability or inability of that antibody to cause hmmolytic disease of the newborn. Blood group antibodies may belong either to the y-globulins with a molecular weight of about 160,000 and a sedimentation constant of 7S, or to those with a molecular weight of about 1,000,000 and a sedimentation constant of 19S. Since cord serum contains only a fraction of the 19S y-globulin present in adult serum (Franklin & Kunkel 1958 , Polley et al. 1962 , those antibodies which are 19S y-globulins are usually unable to gain access to the feetal circulation and, therefore, do not cause hmemolytic disease. The 7S y-globulins, however, can pass to the foetus and it is among this class of antibody that the causative agents of hemolytic disease can be found.
The globulin nature of blood group antibodies can be determined by techniques involving ltracentrifugation (Fudenberg et al. 1959 , Kekwick & Mollison 1961 ), chromatography (Abelson & Rawson 1959 , Fahey & Morrison 1960 , Gunson 1962 , and by use of specially modified antiglobulin reagents (Polley et al. 1962 . Using one or more of these techniques it has been shown by these workers that incomplete Rh antibodies (of any specificity within that system) belong to the 7S y-globulins whereas Rh agglutinins are 19S y-globulins. In the majority of instances where Rh antibodies are found in sera they consist either of incomplete antibody or a mixture of incomplete antibody and agglutinin, but it is interesting to note the case reported by Stratton & Renton (1958) of a mother whose Rh antibody was composed entirely of agglutinin. Her Rh-positive, infant was serologically and clinically normal.
In general, immune antibodies produced as a result of either pregnancy or blood transfusion are 7S y-globulins, e.g. anti-K, anti-Fya and anti- (1961) found an anti-Lewis to consist partly of 19S and partly of 7S y-globulin. Anti-Lewis of this nature may be expected to gain access to the feetal circulation but it would probably not cause major hemolytic disease because of the poor development of the Lewis antigens at birth. Anti-M can also be a 7S y-globulin (Gunson, personal observations) and proof that it can cause hemolytic disease was furnished by Stone & Marsh (1959) . Tomy knowledge anti-P1 has not been implicated in the causation of haemolytic disease. Other antibodies, e.g. anti-S, may be either 'naturally-occurring', or 'immune' and these may be 19S or 7S y-globulins (Gunson, personal observations) .
The serological diagnosis of hemolytic disease caused by any of the antibodies cited above is usually not difficult. The presence of the antibody in the maternal blood, together with a positive direct antiglobulin test with the infant's red cells, and demonstration that the infant's erythrocytes pos-ess the antigen corresponding to the maternal antibody, is usually sufficient. During the antenatal testing of maternal sera, a determination of the globulin nature may help in indicating whether a particular antibody is capable of reaching the ftetal circulation.
Hemolytic disease due to anti-A and anti-B, on the other hand, has presented many problems to the serologist. This has arisen from the difficulties encountered in the definition of the maternal antibody which damages the feetal cells and the fact that the direct antiglobulin test has proved to be of little help in establishing a diagnosis of the disease. Rosenfield & Ohno (1955), using a sensitive antiglobulin technique, obtained a weakly positivereactionwith theredcells of 14 %of infants who were incompatible with their mothers with regard to their ABO groups, and produced haematological evidence to suggest that they were suffering from a mild hwmolytic process. Using his capillary technique, Dr B Chown (personal communication, 1958) found many weakly positive reactions with the red cells of infants whose ABO blood groups differed from those of their mothers.
While working in Dr Chown's laboratory, I was able to study the serological reactions in ABO incompatibility (Gunson 1959) . Since ABO hemo-lytic disease is virtually confined to Group A and B infants born to group 0 mothers, 100 group A and B infants, whose mothers were group 0, were tested. A direct antiglobulin test, using Chown's capillary technique, was done on the cord cells of these infants, and attempts were made to elutd anti-A and anti-B from the infants' cells. The cord serum was tested for the presence of anti-A and anti-B by Low's papain technique using adult group A1 and B cells, and the level of bilirubin was also determined. Hxemoglobin determinations and reticulocyte counts were done using capillary blood taken during the first day of life, and the infants were observed clinically for one week. The maternal sera were tested with a panel of cells to exclude the presence of antibodies other than anti-A and anti-B.
It soon became apparent that evidence of sensitization of the infant's cells could occur without clinical manifestations of the disease, since in 45 instances a positive direct antiglobulin test was obtained and in 42 instances anti-A or anti-B were eluted from the cord cells. Only 14 infants, however, developed jaundice during the first twentyfour hours of life. No indication that the infant would become jaundiced could be gleaned from a study of the reactions in the direct antiglobulin test or in the strength of the antibody eluted from the cells. However, in 22 of the 45 cases where'AB sensitization' was present, homologous antibody was detected in the cord serum, i.e. anti-A in a group A infant and anti-B in a group B infant. On dividing the series into (1) 'AB sensitization' plus free homologous antibody (22 cases), (2) 'AB sensitization' alone (23 cases), and (3) serologically normal infants (55 cases), it was found that group 1 included 10 out of the 14 cases where jaundice was observed, whereas each of the other two groups included 2 cases of jaundice. Since a parallel series of 27 group 0 infants born to group O mothers also included two cases of jaundice within twenty-four hours, it may be that the cause of the jaundice in those infants in groups 2 and 3 was independent of the ABO incompatibility. It was also found that the heemoglobin values of the infants in group 1 tended to be lower than those of the other groups, and the values for the reticulocyte count and cord bilirubin were, in general, higher in group 1 than in groups 2 and 3, but there was such a wide spread in these values that little significance could be attached to them.
From these results it could be concluded that when evidence of 'AB sensitization' of an infant's cells was obtained then the presence of free homologous antibody in the infant's serum was the best means of forecasting that the infant would eventually become jaundiced. If the problem is con-sidered from the aspect of the investigation of jaundice in the newborn infant, then the majority of infants suffering from ABO haemolytic disease have free homologous antibody in their sera. From this point of view, I think that the detection of free homologous antibody in the infant's serum is still the best way to confirm the disease. Its advantages are that it can be done easily and rapidly, using the method described above or, preferably, with papainated A1 or B cells, or by the indirect antiglobulin technique. The majority of the homologous anti-A or anti-B in the cord sera react as 'incomplete' antibodies, but occasionally they are agglutinins. One drawback to the test is that the percentage of positive results in affected infants decreases with the age of the infant at the time of testing, and the presence of the antibody in the infant's serum is not common after 3 to 4 days of age (Gunson 1957 ).
Tests on the mother's serum have been complicated by the presence of 'naturally-occurring' antibodies, although it is now established that the anti-A or anti-B crossing the placenta is a 7S yglobulin in common with other antibodies causing h2emolytic disease of the newborn (Kochwa et al. 1961 ). It has been known for some time that changes occur in the reactions of anti-A and anti-B following immunization to A or B substances, by inoculation with the polysaccharides, either deliberately or as contaminants in vaccines, by incompatible blood transfusion, or by feetal incompatibility during pregnancy. There is often an increase in the titre of the antibody with a shift in the thermal optimum from 160 C to 370 C. Moreover, it is often difficult to neutralize the 'immune' antibodies with A or B polysaccharides and the technique of partial neutralization was evolved by Witebsky (1948) as a means of detecting the presence of 'immune' anti-A and anti-B. Also h2emolysins to A or B cells may appear in the sera, or the strength of an existing hemolysin may be increased.
These features of immunization have all been used in an attempt to establish the diagnosis of ABO h2emolytic disease. It is known that mothers with affected infants possess heemolysins to A or B cells in their sera (Crawford et al. 1953) . Titration of the maternal 'immune' anti-A by the partial neutralization technique bas the disadvantage that many people possess this type of antibody in their sera, and the level of the antibody in a mother's serum at the time of the birth of her affected infant may be no greater than the average. It has, however, been my experience that, in mothers giving birth to infants suffering from ABO himolytic disease, the titre of the 'immune' antibody rises during the first week post-partum 156 Proceedings ofthe Royal Society ofMedicine 6 (Gunson 1957) . This can be used for diagnosis in retrospect, but since at least two titres must be done at intervals of several days it is not much help in the diagnosis of the disease in an infant suffering from jaundice, when treatment may be a pressing matter.
The antenatal prediction of ABO hemolytic disease also has been virtually confined to the 'educated guess', until the recently published work of Tovey et al. (1962) . These workers have used the observations of Winstanley et al. (1957) , that group A pig cells absorb the haemolytic fraction of 'immune' anti-A but do not absorb the 'naturallyoccurring' anti-A, to devise a scheme for testing the sera of group 0 mothers during pregnancy, and in a large series have obtained a remarkably good prediction of the disease and also of its severity. Their observations are extremely interesting and the immunological basis for their results deserves further investigation, since it is not clear as yet that the antibody which is reacting with the AP cells is confined entirely to that which sensitizes the infant's cells. The basis for this comment arises from the fact that similar reactions were observed with Group A and B sera, although with less frequency, and yet the disease is not commonly found in infants born to mothers of these groups.
It is obvious from the foregoing that the final chapter has not been written on ABO hemolytic disease. Despite the recent increases in our knowledge the diagnosis is still often difficult to establish with certainty. Very often one is in the position of having to report that since no other antibodies can be detected the jaundiced infant is 'probably suffering from ABO hemolytic disease'. 
Indications
In our experience at the Hammersmith Hospital the need for exchange transfusion in haemolytic disease of the newborn due to ABO incompatibility does not frequently arise. In the past four and a half years we have given one or more exchange transfusions to 85 newborn infants suffering from Rh incompatibility, but only to 11 with ABO hxemolytic disease out of approximately 11,000 deliveries. We did not start treatment by exchange transfusion ofjaundiced infants without hmmolytic disease until the-beginning of 1959. In three and a half years since we have carried out one or more exchange transfusions on 46 such infants. All but two ofthese were prematurely born and 14 were infants admitted from the district. The aim of exchange transfusion in all three situations is the sameto prevent the accumulation of dangerous concentrations of unconjugated bilirubin within the susceptible cells of the central nervous system. It is well known that for several reasons the level of serum bilirubin is likely to be an imperfect guide to the level of intracellular bilirubin. It is frequently said that a serum bilirubin level of 20 mg/100 ml should not be exceeded, but Mollison & Cutbush (1954) showed that only one of 13 infants with bilirubin levels from 20 to 25 mg/100 ml, and five of 12 infants with levels between 25 and 29 mg/l00ml developed kernicterus. Thus many unnecessary exchange transfusions would be carried out if the avoidance of serum bilirubin levels above 20 mg/100 ml were strictly observed.
It is not always practicable to postpone transfusion until the serum bilirubin has reached the critical level; for instance fresh donor blood is not easily obtainable at night. We therefore try, by doing serum bilirubin estimations in the evening, to predict the bilirubin level the following morning. The greater the number of previous bilirubin determinations in an infant, the more reliable are predictions about future levels. The curve of serum bilirubin level against time is almost invariably concave downwards, and therefore extrapolating the line between the last two points will give a figure for bilirubin level which is very unlikely to be exceeded. It is clear, however, that some unnecessary exchange transfusions are carried out if the indication is based on prediction about future levels of serum bilirubin.
We try to prevent the serum bilirubin rising above 25 mg/100 ml in term babies, above 20 mg/
